A study to investigate safety and efficacy of iGlarLixi in adult patients with Type 2 diabetes mellitus

Trial Identifier: LPS18016
Sponsor: Sanofi
Start Date: January 2025
Primary Completion Date: June 2026
Study Completion Date: June 2026
Condition: Diabetes: Type 2

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
INDIA DELHI, INDIA, 110088
INDIA HYDERABAD, INDIA, 500034
INDIA INDORE, INDIA, 452010
INDIA JAIPUR, INDIA, 302020
INDIA KANPUR, INDIA, 208002
INDIA KOLKATA, INDIA, 700020
INDIA PUNE, INDIA, 411004
INDIA PUNE, INDIA, 411057
INDIA VISAKHAPATNAM, INDIA, 530040